“…At present, the most widely applied biomaterials for bone scaffolds’ production include synthetic polymers (such as polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA) and polylactic-co-glycolic acid (PLGA)) [ 14 , 15 , 16 ], as well as bioceramics (such as β-tricalcium phosphate (β-TCP), hydroxyapatite (HA) and its doped alternatives) [ 17 , 18 , 19 , 20 ]. Polymeric materials have showed great promise as 3D substitutes for bone tissues, particularly for their widely demonstrated biocompatibility, biodegradability and easy processability [ 21 , 22 ]; whereas bioceramics have been mainly investigated for their similarity to the inorganic phase of native bone tissue, and thus for their positive outcomes towards osteointegration, osteoinduction and osteoconduction [ 23 ]. However, given the composite characteristics of native human bone, the promising combination of polymers and ceramics, and where each phase contributes with its own strengths to the final biomaterial-based solution, has been recognized by several research works [ 16 , 24 , 25 , 26 ].…”